Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Type 2 Diabetes market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Type 2 Diabetes market. Detailed analysis of key players, along with key growth strategies adopted by Type 2 Diabetes industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novo Nordisk
Merck
Sanofi
Eli Lily
Boehringer Ingelheim
AstraZeneca
Astellas Pharma
Biocon
Daiichi Sankyo
By Type:
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
By End-User:
Drugstore
Hospital
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Type 2 Diabetes Market
-
1.3 Market Segment by Type
-
1.3.1 China Type 2 Diabetes Market Size and Growth Rate of Insulins from 2016 to 2027
-
1.3.2 China Type 2 Diabetes Market Size and Growth Rate of DPP-4 Inhibitors from 2016 to 2027
-
1.3.3 China Type 2 Diabetes Market Size and Growth Rate of GLP-1 Receptor Agonists from 2016 to 2027
-
1.3.4 China Type 2 Diabetes Market Size and Growth Rate of SGLT-2 Inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Type 2 Diabetes Market Size and Growth Rate of Drugstore from 2016 to 2027
-
1.4.2 China Type 2 Diabetes Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 China Type 2 Diabetes Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Type 2 Diabetes Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Type 2 Diabetes by Major Types
-
3.4.1 Market Size and Growth Rate of Insulins
-
3.4.2 Market Size and Growth Rate of DPP-4 Inhibitors
-
3.4.3 Market Size and Growth Rate of GLP-1 Receptor Agonists
-
3.4.4 Market Size and Growth Rate of SGLT-2 Inhibitors
4 Segmentation of Type 2 Diabetes Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Type 2 Diabetes by Major End-Users
-
4.4.1 Market Size and Growth Rate of Type 2 Diabetes in Drugstore
-
4.4.2 Market Size and Growth Rate of Type 2 Diabetes in Hospital
-
4.4.3 Market Size and Growth Rate of Type 2 Diabetes in Others
5 Market Analysis by Regions
-
5.1 China Type 2 Diabetes Production Analysis by Regions
-
5.2 China Type 2 Diabetes Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Type 2 Diabetes Landscape Analysis
-
6.1 North China Type 2 Diabetes Landscape Analysis by Major Types
-
6.2 North China Type 2 Diabetes Landscape Analysis by Major End-Users
7 Central China Type 2 Diabetes Landscape Analysis
-
7.1 Central China Type 2 Diabetes Landscape Analysis by Major Types
-
7.2 Central China Type 2 Diabetes Landscape Analysis by Major End-Users
8 South China Type 2 Diabetes Landscape Analysis
-
8.1 South China Type 2 Diabetes Landscape Analysis by Major Types
-
8.2 South China Type 2 Diabetes Landscape Analysis by Major End-Users
9 East China Type 2 Diabetes Landscape Analysis
-
9.1 East China Type 2 Diabetes Landscape Analysis by Major Types
-
9.2 East China Type 2 Diabetes Landscape Analysis by Major End-Users
10 Northeast China Type 2 Diabetes Landscape Analysis
-
10.1 Northeast China Type 2 Diabetes Landscape Analysis by Major Types
-
10.2 Northeast China Type 2 Diabetes Landscape Analysis by Major End-Users
11 Southwest China Type 2 Diabetes Landscape Analysis
-
11.1 Southwest China Type 2 Diabetes Landscape Analysis by Major Types
-
11.2 Southwest China Type 2 Diabetes Landscape Analysis by Major End-Users
12 Northwest China Type 2 Diabetes Landscape Analysis
-
12.1 Northwest China Type 2 Diabetes Landscape Analysis by Major Types
-
12.2 Northwest China Type 2 Diabetes Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Novo Nordisk
-
13.1.1 Novo Nordisk Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Merck
-
13.2.1 Merck Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sanofi
-
13.3.1 Sanofi Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lily
-
13.4.1 Eli Lily Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Boehringer Ingelheim
-
13.5.1 Boehringer Ingelheim Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 AstraZeneca
-
13.6.1 AstraZeneca Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Astellas Pharma
-
13.7.1 Astellas Pharma Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Biocon
-
13.8.1 Biocon Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Daiichi Sankyo
-
13.9.1 Daiichi Sankyo Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Type 2 Diabetes Market Size and Growth Rate of Insulins from 2016 to 2027
-
Figure China Type 2 Diabetes Market Size and Growth Rate of DPP-4 Inhibitors from 2016 to 2027
-
Figure China Type 2 Diabetes Market Size and Growth Rate of GLP-1 Receptor Agonists from 2016 to 2027
-
Figure China Type 2 Diabetes Market Size and Growth Rate of SGLT-2 Inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Type 2 Diabetes Market Size and Growth Rate of Drugstore from 2016 to 2027
-
Figure China Type 2 Diabetes Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Type 2 Diabetes Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Type 2 Diabetes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Type 2 Diabetes Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Type 2 Diabetes
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Type 2 Diabetes by Different Types from 2016 to 2027
-
Table Consumption Share of Type 2 Diabetes by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Insulins
-
Figure Market Size and Growth Rate of DPP-4 Inhibitors
-
Figure Market Size and Growth Rate of GLP-1 Receptor Agonists
-
Figure Market Size and Growth Rate of SGLT-2 Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Type 2 Diabetes by Different End-Users from 2016 to 2027
-
Table Consumption Share of Type 2 Diabetes by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Drugstore
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Others
-
Table China Type 2 Diabetes Production by Regions
-
Table China Type 2 Diabetes Production Share by Regions
-
Figure China Type 2 Diabetes Production Share by Regions in 2016
-
Figure China Type 2 Diabetes Production Share by Regions in 2021
-
Figure China Type 2 Diabetes Production Share by Regions in 2027
-
Table China Type 2 Diabetes Consumption by Regions
-
Table China Type 2 Diabetes Consumption Share by Regions
-
Figure China Type 2 Diabetes Consumption Share by Regions in 2016
-
Figure China Type 2 Diabetes Consumption Share by Regions in 2021
-
Figure China Type 2 Diabetes Consumption Share by Regions in 2027
-
Table North China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table North China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure North China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure North China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure North China Type 2 Diabetes Consumption Share by Types in 2027
-
Table North China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table North China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure North China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure North China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure North China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table Central China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table Central China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure Central China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure Central China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure Central China Type 2 Diabetes Consumption Share by Types in 2027
-
Table Central China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table Central China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure Central China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure Central China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table South China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table South China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure South China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure South China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure South China Type 2 Diabetes Consumption Share by Types in 2027
-
Table South China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table South China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure South China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure South China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure South China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table East China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table East China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure East China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure East China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure East China Type 2 Diabetes Consumption Share by Types in 2027
-
Table East China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table East China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure East China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure East China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure East China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table Northeast China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table Northeast China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure Northeast China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure Northeast China Type 2 Diabetes Consumption Share by Types in 2027
-
Table Northeast China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table Northeast China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure Northeast China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure Northeast China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table Southwest China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table Southwest China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure Southwest China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure Southwest China Type 2 Diabetes Consumption Share by Types in 2027
-
Table Southwest China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table Southwest China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure Southwest China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure Southwest China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table Northwest China Type 2 Diabetes Consumption by Types from 2016 to 2027
-
Table Northwest China Type 2 Diabetes Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Type 2 Diabetes Consumption Share by Types in 2016
-
Figure Northwest China Type 2 Diabetes Consumption Share by Types in 2021
-
Figure Northwest China Type 2 Diabetes Consumption Share by Types in 2027
-
Table Northwest China Type 2 Diabetes Consumption by End-Users from 2016 to 2027
-
Table Northwest China Type 2 Diabetes Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Type 2 Diabetes Consumption Share by End-Users in 2016
-
Figure Northwest China Type 2 Diabetes Consumption Share by End-Users in 2021
-
Figure Northwest China Type 2 Diabetes Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Eli Lily
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lily
-
Figure Sales and Growth Rate Analysis of Eli Lily
-
Figure Revenue and Market Share Analysis of Eli Lily
-
Table Product and Service Introduction of Eli Lily
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
